|
J Biol Chem, Vol. 275, Issue 13, 9805-9813, March 31, 2000
Apoptosis Signal-regulating Kinase 1 (ASK1) Induces Neuronal
Differentiation and Survival of PC12 Cells*
Kohsuke
Takeda ,
Takiko
Hatai,
Tatsuo S.
Hamazaki,
Hideki
Nishitoh,
Masao
Saitoh, and
Hidenori
Ichijo
From the Department of Biomaterials Science, Faculty of Dentistry,
Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku,
Tokyo 113-8549, Japan
 |
ABSTRACT |
Apoptosis signal-regulating kinase 1 (ASK1) is a
ubiquitously expressed mitogen-activated protein kinase kinase kinase
that activates the c-Jun N-terminal kinase (JNK) and p38
mitogen-activated protein kinase signaling cascades. We report here
that expression of constitutively active ASK1 (ASK1 N) induces
neurite outgrowth in the rat pheochromocytoma cell line PC12. We found
that p38 and to a lesser extent JNK, but not ERK, were activated by the expression of ASK1 N in PC12 cells. ASK1 N-induced neurite
outgrowth was strongly inhibited by treatment with the p38 inhibitor
SB203580 but not with the MEK inhibitors, suggesting that activation of p38, rather than of ERK, is required for the neurite-inducing activity
of ASK1 in PC12 cells. We also observed that ASK1 N induced expression of several neuron-specific proteins and phosphorylation of
neurofilament proteins, confirming that PC12 cells differentiated into
mature neuronal cells by ASK1. Moreover, ASK1 N-expressing PC12 cells
survived in serum-starved condition. ASK1 thus appears to mediate
signals leading to both differentiation and survival of PC12 cells.
Together with previous reports indicating that ASK1 functions as a
pro-apoptotic signaling intermediate, these results suggest that ASK1
has a broad range of biological activities depending on cell types
and/or cellular context.
 |
INTRODUCTION |
The rat pheochromocytoma cell line PC12 is a useful model of
neuronal differentiation and death (1). On treatment with nerve growth
factor (NGF),1 PC12 cells
differentiate with sympathetic neuron-like characteristics including
neurite outgrowth. Upon binding of NGF, the cell surface receptor
tyrosine kinase is activated, and the activated kinase in turn
activates the small GTP-binding protein Ras followed by sequential
phosphorylation and activation of three members of the
mitogen-activated protein kinase (MAPK) superfamily, MAPK kinase kinase
(MAPKKK)/Raf, MAPK kinase (MAPKK)/MEK, and MAPK/extracellular signal-regulated kinase (ERK) (2-4). Activation of the ERK pathway is
thought to play roles during NGF-induced neuronal differentiation, since constitutively active MEK induced neurite outgrowth and selective
blockade of the ERK pathway using dominant-negative MEK or the MEK
inhibitor PD98059 resulted in inhibition of NGF-induced neurite
outgrowth (5-7). It has also been suggested that persistence of ERK
activation is critical for differentiation of PC12 cells, since
transient activation of ERK induced by agents such as EGF is
insufficient to induce neurite outgrowth (8-10).
However, a contradictory finding was recently reported, in which an
interfering mutant of the small G protein Rap1 which blocks the
sustained phase of ERK activation did not inhibit NGF-induced neurite
outgrowth, suggesting that sustained activation of ERK is not
necessarily required for NGF-induced neuronal differentiation (11). In
another study, NGF-induced neurite outgrowth of PC12D cells, a subline
of PC12 cells, was shown to be resistant to the addition of PD98059
(12). Furthermore, neuronal differentiation of PC12 cells by treatment
with bone morphogenetic protein (BMP)-2 was induced in the absence of
ERK activation (13). These studies strongly suggest that signaling
pathways other than the ERK cascade also contribute to neuronal
differentiation of PC12 cells.
Candidates for signaling pathways regulating neuronal cell death and
differentiation include two different recently identified MAPK cascades
that converge on c-Jun N-terminal kinase (JNK; also known as SAPK,
stress-activated protein kinase) and p38 MAP kinase. Whereas the ERK
signaling cascade is generally involved in the control of cell
proliferation and differentiation, JNK and p38 are preferentially
activated by cytotoxic stressors such as UV radiation, x-rays, heat
shock and osmotic shock, and by proinflammatory cytokines such as tumor
necrosis factor (TNF) and interleukin-1 (14-16). Importantly,
activation of the JNK and/or p38 pathway has been observed in response
to deprivation of trophic factors in differentiated PC12 cells and
other neuronal cells, suggesting the possible involvement of JNK and
p38 in neuronal death (17-20). When the JNK pathway was inhibited
using a dominant-interfering c-Jun mutant, neuronal death elicited by
trophic factor withdrawal was decreased, implying that the JNK pathway
is a necessary component of neuronal death induced by trophic factor
deprivation. Moreover, mice lacking the JNK3 gene, a member
of the JNK family (21), and JunAA mice, in which endogenous
Jun is replaced by a dominant-negative mutant Jun
allele (22), were reported to exhibit marked reduction in
excitotoxicity-induced apoptosis of hippocampal neurons, clearly demonstrating the requirement of JNK activity for neuronal death. More
recently, compound mutant mice lacking the JNK1 and
JNK2 genes were shown to be embryonic lethal and have severe
dysregulation of apoptosis in brain, suggesting that JNK1 and JNK2
regulate region-specific apoptosis during early brain development
(23).
On the other hand, several lines of evidence have suggested that the
JNK and p38 pathways are involved in neuronal differentiation. Differentiation of PC12 cells induced by expression of
GTPase-deficient, constitutively active forms of the heterotrimeric
Gq family members, G q and
G 16, was accompanied by persistent activation of JNK but
not of ERK (24). Expression of constitutively activated c-Jun, which
partly mimicked the phosphorylated form of the protein, or
retrovirus-mediated overexpression of c-Jun induced neuronal differentiation of PC12 cells independently of upstream signals (25).
Staurosporine, a protein kinase inhibitor and promoter of neurite
outgrowth in PC12 cells, specifically induced prolonged activation of a
novel JNK isoform (26). In addition, p38 was recently shown to be
activated in response to NGF and to be required for NGF-induced
differentiation of PC12 cells (27, 28). More recently, it was reported
that p38 was activated by treatment with BMP-2 in PC12 cells and that
activation of p38 might be sufficient to induce neuronal
differentiation of PC12 cells (29). These observations suggested that
the JNK and p38 pathways mediate important biological signals not only
for neuronal cell death but also for neuronal differentiation.
Apoptosis signal-regulating kinase 1 (ASK1) is a ubiquitously expressed
MAPKKK that activates the SEK1-JNK and MKK3/MKK6-p38 signaling cascades
(30). Overexpression of ASK1 in epithelial cells in low serum condition
induced apoptosis, and in ovarian cancer cells expression of a
kinase-inactive mutant of ASK1 inhibited microtubule-interfering
agent-induced apoptosis, suggesting that ASK1 plays a role in the
mechanism of stress-induced apoptosis (30-32). We recently found that
overexpression of ASK1 induced death of NGF-differentiated PC12 cells
and primary rat sympathetic neurons (SCGs). Moreover, dominant-negative
ASK1 reduced the neuronal death induced by NGF withdrawal from these
cells (33). ASK1 was activated upon treatment with TNF- or agonistic
anti-Fas antibody, and a kinase-inactive mutant of ASK1 reduced
TNF- - and Fas-induced JNK activation and apoptosis, suggesting that ASK1 is a pivotal component in cytokine-induced apoptosis as well (30,
34, 35). Considering the involvement of JNK and p38 in neuronal death
and differentiation as described above, it is of great interest whether
ASK1 mediates signals leading to death or differentiation of
undifferentiated PC12 cells.
We report here that transient or stable expression of constitutively
active ASK1 (ASK1 N) induces neurite outgrowth in PC12 cells. We
found that p38 and to a lesser extent JNK, but not ERK, were activated
by expression of ASK1 N in PC12 cells. Experiments using MEK
inhibitors and a p38 inhibitor suggested a significant contribution of
activation of p38, rather than of ERK, to the neurite-inducing activity
of ASK1 in PC12 cells. We also found that ASK1 N induced expression
of several neuron-specific proteins and phosphorylation of
neurofilament proteins, confirming that PC12 cells differentiated into
mature neuronal cells by expression of ASK1 N. Moreover, we found
that ASK1 N-expressing PC12 cells survived in serum-starved
condition. Taken together, these findings suggest that ASK1 may mediate
signals leading to both differentiation and survival of
undifferentiated PC12 cells.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
Wild-type (WT)-PC12 cells were obtained from
the RIKEN Cell Bank (Tsukuba, Japan). PC12 cells were cultured in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%
fetal calf serum (FCS), 10% heat-inactivated horse serum (HS), and 100 units/ml penicillin G in a 5% CO2 atmosphere at
37 °C.
Antibodies and Reagents--
Rat monoclonal antibody to the
hemagglutinin (HA) tag (clone 3F10) was purchased from Roche Molecular
Biochemicals. Anti-SAPK/JNK polyclonal antibody, anti-ERK polyclonal
antibody, and phospho-specific polyclonal antibodies to p38 MAP kinase
(Thr-180/Tyr-182) and SAPK/JNK (Thr-183/Tyr-185) were purchased from
New England Biolabs. Phospho-specific polyclonal antibody to ERK
(Thr-183/Tyr-185) was purchased from Promega. Anti-p38 MAP kinase goat
polyclonal antibody (C-20-G), anti-neurofilament medium subunits (NF-M)
polyclonal antibody, and anti-Tau monoclonal antibody were purchased
from Santa Cruz Biotechnology Inc., Affiniti Research Products Ltd., and Transduction Laboratories, respectively. Monoclonal antibody to
neurofilament heavy subunits (NF-H) clone RMO-24, which specifically recognizes a phosphate-dependent epitope in the tail domain
of NF-H (36, 37), was purchased from Zymed Laboratories
Inc.. Anti-NF-H monoclonal antibody clone N52, which recognizes
phosphorylated and non-phosphorylated NF-H, and anti- -tubulin
isotype III monoclonal antibody were purchased from Sigma.
SB203580, PD98059, and U0126 were purchased from Calbiochem, New
England Biolabs, and Promega, respectively. Mouse 2.5S NGF was
purchased from Takara.
Adenovirus Vectors--
Recombinant adenoviruses encoding
HA-tagged ASK1 mutants and -galactosidase were constructed as
described (31). Nearly 100% infection of recombinant adenoviruses to
PC12 cells can be achieved at a multiplicity of infection (m.o.i.) of
100 as determined by -galactosidase staining (data not shown).
Tetracycline (Tet)-regulated Expression System--
The
hygromycin resistance gene derived from pBHMr and the neomycin
resistance gene derived from pABWN were each subcloned into pTet-tTAk
plasmid (Life Technologies, Inc.) and pTet-Splice (Life Technologies,
Inc.) and named pTet-tTAk-hyg and pTet-Splice-neo, respectively. The
cDNA for HA-tagged ASK1 N (HA-ASK1 N) was then subcloned into
pTet-Splice-neo. The pTet-tTAk-hyg plasmid was transfected into PC12
cells using DMRIE-C (Life Technologies, Inc.) according to the
manufacturer's instruction. The cells were then selected with 240 units/ml hygromycin B (Wako), and several hygromycin-resistant clones
were established. A clone termed PC12-tTA was further transfected with
pTet-Splice-neo-based expression vector for HA-ASK1 N. After
selection with 400 µg/ml neomycin (Geneticin, Life Technologies,
Inc.) and 240 units/ml hygromycin, the double-resistant clones were
established and analyzed for the expression of HA-ASK1 N proteins by
Western blot. The cells were maintained in DMEM supplemented with 10%
FCS, 10% HS, 100 units/ml penicillin G, 500 ng/ml Tet (Sigma), 120 units/ml hygromycin, and 200 µg/ml neomycin.
Neurite Outgrowth Assay--
Approximately 1 × 105 WT-PC12 cells per well were plated in 6-well cell
culture plates (Becton Dickinson Labware) coated with bovine type IV
collagen (Cellmatrix, Nitta Gelatin) and allowed to grow in DMEM
supplemented with 10% FCS and 10% HS for overnight. Cells were then
washed twice with phosphate-buffered saline (PBS) and refed with DMEM
containing 1% HS and a recombinant adenovirus encoding HA-ASK1 N or
-galactosidase. Twenty-four hours after infection, cells were washed
with PBS and further cultured in DMEM containing 1% HS for an
additional 48 h. In the case of PC12-ASK1 N cells, approximately
1 × 105 cells per well were plated in type IV
collagen-coated 6-well cell culture plates and allowed to grow in DMEM
supplemented with 10% FCS, 10% HS, and 500 ng/ml Tet overnight. Cells
were then washed twice with PBS and refed with DMEM containing 1% HS
and given concentrations of Tet. To determine the percentage of
neurite-bearing cells, the number of cells with a process longer than
one cell diameter was determined and compared with the total number of cells counted.
Western Blot Analysis--
Cells were lysed in a lysis buffer
containing 150 mM NaCl, 50 mM Tris-HCl, pH 8.0, 1% Nonidet P-40, 0.5% deoxycholate, and 0.1% SDS, and cell extracts
were clarified by centrifugation. To detect the expression of neuronal
marker proteins, cells were lysed in the same lysis buffer except with
the concentration of SDS increased to 1% and sonicated briefly before
clarification by centrifugation. The protein concentration of the
supernatant was measured using a DC Protein Assay (Bio-Rad), and the
same amounts of protein were resolved on SDS-polyacrylamide gel
electrophoresis and electroblotted onto polyvinylidene difluoride
membranes. After blocking with 5% skim milk in TBS-T (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, and 0.05%
Tween 20) for 1 h, the membranes were probed with antibodies. The
antibody-antigen complexes were detected using the ECL system (Amersham
Pharmacia Biotech).
Survival Assay--
Approximately 5 × 104
PC12-ASK1 N cells per well were plated in type IV collagen-coated
24-well cell culture plates and allowed to grow in DMEM supplemented
with 10% FCS, 10% HS, and 500 ng/ml Tet overnight. The cells were
washed twice with PBS and refed with serum-free DMEM containing given
concentrations of Tet (day 0). Using an
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
assay-based Cell Counting Kit-8 (Dojindo), relative cell numbers were
determined in triplicate by estimating the value of day 0 as 1.
 |
RESULTS |
Constitutively Active ASK1 Induces Neurite Outgrowth in PC12
Cells--
To investigate the roles played by ASK1 in neuronal cells,
we examined the effect of expression of ASK1 N, a constitutively active mutant of ASK1 (31), in PC12 cells. First, wild-type (WT)-PC12
cells were infected with recombinant adenoviruses encoding hemagglutinin (HA) epitope-tagged ASK1 N (Ad-ASK1 N) or
-galactosidase (Ad- -galactosidase) in culture medium containing
1% horse serum (HS). Nearly 100% infection of recombinant
adenoviruses to WT-PC12 cells was achieved at an m.o.i. of 100 as
determined by -galactosidase staining (data not shown). With Western
blot analysis using a monoclonal anti-HA antibody, expression of
ASK1 N was detected in an m.o.i.-dependent manner 24 h after infection (Fig. 1A). Unexpectedly, at this time point, Ad-ASK1 N-infected cells began to
sprout neurites (data not shown). To confirm the neurite-inducing activity of ASK1, WT-PC12 cells left uninfected or infected with Ad-ASK1 N were cultured for 72 h and examined by phase-contrast microscopy. The cells infected with Ad-ASK1 N (m.o.i. of 100) exhibited marked extension of neurites (Fig. 1B, right
panel), whereas uninfected cells exhibited no neurite extension
(Fig. 1B, left panel). When cells with a neurite longer than
one cell diameter were counted, the percentage of neurite-bearing cells increased by Ad-ASK1 N infection in an m.o.i.-dependent
manner (Fig. 1C). Taken together with the observation that
infection with Ad-ASK1KM, a recombinant adenovirus encoding a
kinase-inactive mutant of ASK1 (31), or Ad- -galactosidase failed to
induce neurite outgrowth in PC12 cells (data not shown), these findings indicate that the neurite outgrowth induced by infection with Ad-ASK1 N is dependent on the kinase activity of ASK1.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Constitutively active ASK1
(ASK1 N)-induced neurite outgrowth in WT-PC12
cells. A, adenovirus-mediated expression of ASK1 N in
WT-PC12 cells. WT-PC12 cells were infected with the indicated m.o.i. of
a recombinant adenovirus encoding HA-tagged ASK1 N
(Ad-ASK1 N). Twenty-four h after the infection, cells were
lysed and immunoblotted with a monoclonal antibody to HA. B,
induction of neurite outgrowth in WT-PC12 cells. WT-PC12 cells were
infected with an m.o.i. 100 of Ad-ASK1 N in DMEM containing 1% HS.
Twenty-four h after the infection, cells were washed with PBS and
further cultured in fresh medium for an additional 48 h.
Morphology of uninfected cells (left panel) and
Ad-ASK1 N-infected cells (right panel) was examined by
phase-contrast microscopy. Bar, 50 µm. C,
dose-dependent effect of Ad-ASK1 N on neurite outgrowth
in WT-PC12 cells. WT-PC12 cells were infected with the indicated m.o.i.
of Ad-ASK1 N in DMEM containing 1% HS. Twenty-four h after
infection, cells were washed with PBS and further cultured in fresh
medium for an additional 48 h. The percentage of cells with a
process longer than one cell diameter was determined. Results are the
means of three independent experiments ± S.E.
|
|
To examine further the roles of ASK1 in PC12 cells, we established a
stable cell line expressing HA-tagged ASK1 N (PC12-ASK1 N cells),
in which the expression of ASK1 N is under the control of a
Tet-repressible promoter (see "Experimental Procedures"). After the
complete removal of Tet from the culture medium, expression of ASK1 N
was turned on and first detectable as early as 3 h later by
Western blot analysis (data not shown). Twenty-four h after the
reduction of Tet in the culture medium, no leaky expression of ASK1 N
was detected in the presence of Tet (500 ng/ml), and the level of
ASK1 N expression was tightly controlled by the concentration of Tet
(Fig. 2A). Fig. 2B
shows representative morphology of PC12-ASK1 N cells expressing (Tet
0 ng/ml) or not expressing (Tet 500 ng/ml) ASK1 N 24 h after the
reduction of Tet. The ASK1 N-expressing cells exhibited marked
extension of neurites, similar to WT-PC12 cells infected with
Ad-ASK1 N.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 2.
Induction of neurite outgrowth in PC12 cells
stably transfected with HA-ASK1 N
(PC12-ASK1 N cells). A,
expression of ASK1 N in PC12-ASK1 N cells. PC12-ASK1 N cells,
stably expressing HA-tagged ASK1 N under the control of a
Tet-repressible promoter, were cultured in DMEM containing 1% HS and
the indicated concentration of Tet for 24 h. Cells were then lysed
and immunoblotted with a monoclonal antibody to HA. B,
induction of neurite outgrowth in PC12-ASK1 N cells. PC12-ASK1 N
cells were cultured in DMEM containing 1% HS in the presence
(left panel) or absence (right panel) of Tet.
Twenty-four h after the reduction of Tet, cell morphology was examined
by phase-contrast microscopy. Bar, 50 µm. C,
time course quantification of neurite-bearing PC12-ASK1 N cells at
different concentrations of Tet. PC12-ASK1 N cells were cultured in
DMEM containing 1% HS in the presence of the indicated concentration
of Tet. The percentage of cells with a process longer than one cell
diameter was determined at different time points after the reduction of
Tet. Results are the means of three independent experiments.
|
|
We next examined the time and concentration effects of Tet on the
induction of neurite outgrowth in PC12-ASK1 N cells. Twenty-four h
after the reduction of Tet, approximately 15% of cells extended neurites with 50 ng/ml Tet (Fig. 2C). With 0 or 10 ng/ml of
Tet, the proportion of neurite-bearing cells increased to approximately 45-50% in parallel with the expression of ASK1 N protein detected by Western blot (Fig. 2, A and C). Forty eight h
after the reduction of Tet, the proportion of neurite-bearing cells
further increased in a time-dependent manner with 50 or 10 ng/ml Tet. However, when Tet was completely removed from the culture
medium (Tet 0 ng/ml), the proportion of neurite-bearing cells peaked at
24 h but was decreased at 48 and 72 h. With a longer period
of culture (up to 2 weeks), ASK1 N-induced neurite outgrowth was
found to be most prominent at 10 ng/ml Tet (data not shown).
ASK1 N Preferentially Activates the p38 MAP Kinase Pathway in
PC12 Cells--
ASK1 activates the JNK and p38 MAP kinase pathways in
COS cells (30). To explore the signaling pathway(s) leading to the induction of neurite outgrowth by ASK1, we examined which MAP kinase
cascade is activated in PC12 cells by the expression of ASK1 N. To
measure the activation status of endogenous ERK, JNK, and p38, we
performed Western blot analysis using polyclonal antibodies that
specifically recognize the dually phosphorylated active forms of these
enzymes. We tested the dose-dependent effect of ASK1 N expression on activation of MAPKs in PC12-ASK1 N cells 24 h
after the reduction of Tet (Fig.
3A). Consistent with our
previous report for COS cells (30), an intense activation of p38 was
readily detected with expression of ASK1 N. When the same membrane
was reprobed with anti-phospho-JNK antibody, intense signals
corresponding to phosphorylated p54 and p46 isoforms of JNK were
detected in the lysate of sorbitol-treated cells, indicating the
presence of intact signaling components leading to JNK in this cell
line. Unexpectedly, in contrast to p38, JNK was barely activated by ASK1 N; only marginal activation of JNK was detected when an excess amount of ASK1 N was expressed at 10 or 0 ng/ml Tet. We detected no
clear increase in ERK activation induced by ASK1 N on reprobing the
same membrane with the anti-phospho-ERK antibody (data not shown; see
below).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of ASK1 N
expression on p38 and JNK in PC12 cells. A,
preferential activation of p38 by ASK1. PC12-ASK1 N cells were
cultured in DMEM containing 1% HS and the indicated concentration of
Tet for 24 h. As positive controls for activation of JNK and p38,
cells were exposed to 0.5 M sorbitol for 5 min in the
presence of 500 ng/ml Tet. Cells were then lysed and immunoblotted with
specific antibodies to HA, phosphorylated p38, total p38,
phosphorylated JNK, and total JNK. B, time course of
activation of p38 and JNK with different concentrations of Tet in
PC12-ASK1 N cells. PC12-ASK1 N cells were cultured in DMEM
containing 1% HS and the indicated concentration of Tet for 24, 48, and 72 h. Cells were lysed at each time point and immunoblotted
with specific antibodies as indicated. As a positive control, the
lysate of the cells exposed to 0.5 M sorbitol for 5 min in
the presence of 500 ng/ml Tet was used (indicated as S).
C, activation of p38 in WT-PC12 cells by infection with
Ad-ASK1 N. WT-PC12 cells were infected with an m.o.i. 50 (+) or 200 (++) of Ad-ASK1 N or an m.o.i. 100 (+) or 400 (++) of Ad-ASK1KM for
24 h. As a positive control, cells were exposed to 0.5 M sorbitol for 5 min. Cells were then lysed and
immunoblotted with specific antibodies to HA, phosphorylated p38, and
total p38.
|
|
We next examined the time course effects of ASK1 N on JNK and p38 in
PC12-ASK1 N cells (Fig. 3B). In this experiment, we used the same sets of Tet concentration and time points as those in Fig.
2C, in order to determine the correlation between the
ASK1 N-induced neurite outgrowth and the activation of downstream
MAPKs. With 50 ng/ml Tet, expression of ASK1 N increased
time-dependently and reached a plateau at 48 h, and
constant activation of p38 was maintained from 24 to 72 h. On the
other hand, activation of JNK was first detectable 72 h after
reduction of Tet. Neither p38 nor JNK was activated in the cells
maintained in the presence of Tet (500 ng/ml) throughout the time
course of observation. At 10 or 0 ng/ml Tet, activation of p38 peaked
at 24 h and decreased thereafter in accordance with the expression
level of ASK1 N, whereas clear activation of JNK was first detected
48 h after reduction of Tet. The preferential activation of p38 by
ASK1 N was further confirmed in WT-PC12 cells, which we infected with Ad-ASK1 N or Ad-ASK1KM and tested for activation of MAPKs 24 h after infection. Although there was a quantitative difference in the
adenovirus-mediated expression of ASK1 N and ASK1KM, expression of
ASK1 N, but not of ASK1KM, clearly activated p38 but not JNK or ERK
(Fig. 3C and data not shown). These observations strongly suggest that ASK1 N preferentially activates the p38 pathway in PC12
cells. Furthermore, together with the observation that ASK1 N-induced neurite outgrowth was already found within 24 h after the
induction of ASK1 N, it is likely that p38, rather than JNK or ERK,
plays a primary role in ASK1 N-induced neurite outgrowth in PC12 cells.
Basal Activity of ERK Only Minimally Contributes to
ASK1 N-induced Neurite Outgrowth--
It has been suggested
that activation of the ERK pathway plays crucial roles in
NGF-induced neuronal differentiation. Since we did not detect
ASK1 N-dependent activation of ERK in either WT-PC12 or
PC12-ASK1 N cells, we examined whether basal activity of ERK is
required for ASK1 N-induced neurite outgrowth (Fig. 4). In PC12-ASK1 N cells, a relatively
high level of basal phosphorylation of ERK was observed in the presence
of 500 ng/ml Tet, but no additional phosphorylation was induced by
expression of ASK1 N. In the presence of 10 mM each of
the MEK inhibitors PD98059 and U0126, the phosphorylation of ERK was
partially and completely inhibited by PD98059 and U0126, respectively.
When the percentage of neurite-bearing cells was determined 48 h
after the induction of ASK1 N in the presence or absence of the MEK
inhibitors, PD98059 and U0126 were found to only slightly decrease the
number of neurite-bearing cells. Importantly, despite the obvious
difference in ERK phosphorylation status, no significant difference was
detected between PD98059 and U0126 in ability to modulate
ASK1 N-induced neurite outgrowth. These results suggest that the ERK
pathway makes little contribution, if any, to ASK1 N-induced neurite
outgrowth in PC12 cells.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of MEK inhibitors on
ASK1 N-induced neurite outgrowth in
PC12-ASK1 N cells. PC12-ASK1 N cells
were plated in duplicate in 6-well cell culture plates and cultured in
DMEM containing 1% HS and 500 or 10 ng/ml Tet in the presence or
absence of 10 µM MEK inhibitors. The MEK inhibitors,
PD98059 and U0126, are indicated as PD and U,
respectively. Cells in one plate were lysed 24 h after the
reduction of Tet and immunoblotted with specific antibodies to
phosphorylated ERK, total ERK, and HA. The cells in another plate were
used for quantification of neurite outgrowth 48 h after reduction
of Tet. The percentage of cells with a process longer than one cell
diameter was determined. Results are the means of three independent
experiments ± S.E.
|
|
SB203580 Inhibits ASK1 N-induced Neurite Outgrowth--
To
assess the requirement of p38 for ASK1 N-induced neurite outgrowth,
we examined the effect of SB203580, a specific inhibitor of p38, on the
neurite-inducing activity of ASK1 N. When PC12-ASK1 N cells were
induced to extend neurites in the presence or absence of SB203580,
ASK1 N-induced neurite outgrowth was inhibited in the presence of
only 200 nM SB203580 (Fig.
5A). We confirmed that this
concentration of SB203580 had no cytotoxic effect on PC12-ASK1 N cells (data not shown). Fig. 5B shows that the
neurite-inducing activity of ASK1 N was inhibited in a
dose-dependent manner by addition of SB203580. Since the
presence of higher concentrations above 200 nM SB203580 in
the culture medium decreased the expression of ASK1 N, we could not
determine whether higher concentrations of SB203580 completely
inhibited ASK1 N-induced neurite outgrowth. However, these findings
strongly suggest that p38 is required for the neurite outgrowth
induced by ASK1 N.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of SB203580 on
ASK1 N-induced neurite outgrowth in
PC12-ASK1 N cells. A,
morphological examination of the effect of SB 203580 on
ASK1 N-induced neurite outgrowth. PC12-ASK1 N cells were cultured
in DMEM containing 1% HS and 10 ng/ml Tet in the presence (right
panel) or absence (left panel) of SB203580 for 48 h. Cell morphology was examined by phase-contrast microscopy.
Bar, 50 µm. B, dose-dependent
effect of SB203580 on ASK1 N-induced neurite outgrowth. PC12-ASK1 N
cells were cultured in DMEM containing 1% HS and 10 ng/ml Tet in the
presence of different concentrations of SB203580 for 48 h. The
percentage of cells with a process longer than one cell diameter was
determined. Results are the means of three independent experiments ± S.E.
|
|
Characterization of ASK1-induced Differentiation of PC12
Cells--
To confirm that the neurite outgrowth induced by ASK1 N
was accompanied by neuronal differentiation of PC12 cells, we examined the expression of several neuron-specific proteins as markers of
neuronal differentiation. For comparison with NGF-induced
differentiation, PC12-ASK1 N cells were cultured in parallel in the
presence of 50 ng/ml NGF and 500 ng/ml Tet. PC12-tTA cells, the
parental cell line of PC12-ASK1 N cells that stably expresses only
the gene for a tetracycline transactivator (see "Experimental
Procedures"), were also cultured under the same conditions. After
culture for 10 days with or without induction of ASK1 N, cells were
lysed and subjected to Western blot analysis using a variety of
antibodies to neuron-specific markers (Fig.
6A). -Tubulin isoform III
(tubulin- III) is synthesized exclusively by neurons of higher
vertebrates and increases in conjunction with the rate of neuronal
differentiation (38). By using a monoclonal antibody to tubulin- III,
we detected a marked increase in the expression of tubulin- III
following treatment with NGF in both PC12-ASK1 N and PC12-tTA cells.
PC12-ASK1 N cells but not PC12-tTA cells cultured in the reduced
concentration of Tet also exhibited a dramatic increase in the
expression of tubulin- III, indicating that the up-regulation of
tubulin- III was induced by the expression of ASK1 N and was not a
nonspecific effect of Tet reduction from the culture medium. Similar
results were achieved using a monoclonal antibody to Tau, which is a
group of microtubule-associated proteins (MAPs), and is known to be selectively expressed in unique subsets of neurons (39). Consistent with a previous report (40), expression of Tau was up-regulated in both
cells by treatment with NGF. Expression of ASK1 N also increased Tau
protein in PC12-ASK1 N cells. These results indicated that
ASK1 N-induced morphological change of PC12-ASK1 N cells was
accompanied by up-regulation of neuron-specific components of
microtubules, as was the case with NGF-induced differentiation.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of ASK1 N
expression on neuron-specific proteins in PC12 cells.
A, effect of ASK1 N expression on neuron-specific proteins
in PC12-ASK1 N and PC12-tTA cells. PC12-ASK1 N and PC12-tTA cells
were cultured in DMEM containing 1% HS and 500 (+) or 10 ng/ml ( )
Tet in the presence (+) or absence ( ) of 50 ng/ml NGF for 10 days.
Cells were then lysed and immunoblotted with specific antibodies to
phosphorylated NF-H, total NF-H, NF-M, Tau, tubulin- III, and HA.
B, effect of ASK1 N expression on neuron-specific proteins
in WT-PC12 cells. WT-PC12 cells were infected with Ad-ASK1 N or
Ad- -galactosidase (Ad- -gal) in the presence (+) or
absence ( ) of 50 ng/ml NGF in DMEM containing 1% HS. Twenty-four h
after the infection, the cells were washed with PBS and further
cultured in fresh medium for an additional 48 h. Cells were lysed
and immunoblotted with specific antibodies to phosphorylated NF-H,
total NF-H, and HA. C, time course of phosphorylation of
NF-H induced by expression of ASK1 N in PC12-ASK1 N cells.
PC12-ASK1 N cells were cultured in DMEM containing 1% HS in the
presence (+) or absence ( ) of Tet. Cells were lysed at the indicated
time points and immunoblotted with antibodies to phospho-NF-H, total
NF-H, HA, phospho-p38, and total p38.
|
|
We next examined the expression of neurofilament proteins, which are
major elements of the neuronal cytoskeleton. Neurofilaments are
composed of three intermediate filament proteins, neurofilament light
(NF-L), neurofilament medium (NF-M), and neurofilament heavy (NF-H). Of
these three subunits, NF-M and NF-H have extensive C-terminal domains
including major phosphorylation sites (41). In untreated PC12-ASK1 N
and PC12-tTA cells, a polyclonal antibody to NF-M detected endogenous
NF-M as a doublet band. Since this antibody recognizes NF-M
independently of its phosphorylation state, the observed slower and
faster migrated bands were thought to correspond to phosphorylated and
non-phosphorylated forms of NF-M, respectively. In both cells,
treatment with NGF significantly increased both the phosphorylated and
non-phosphorylated forms of NF-M. Interestingly, expression of
ASK1 N in PC12-ASK1 N cells induced a band shift of NF-M without a
change in total amount, suggesting that ASK1 N induces
phosphorylation of NF-M in vivo. A monoclonal antibody that
recognizes NF-H independently of its phosphorylation state detected
endogenous NF-H as a single band in untreated PC12-ASK1 N and
PC12-tTA cells. When the cells were treated with NGF, expression of
NF-H was detected as a broad band, suggesting that NGF up-regulates
both protein level and phosphorylation of NF-H. Notably, expression of
NF-H in the ASK1 N-expressing cells was also detected as a broad band
with extremely slowly migrating species, suggesting that expression of
ASK1 N strongly induces phosphorylation of NF-H. To confirm the
ASK1 N-induced phosphorylation of NF-H, we next used a monoclonal
antibody that specifically recognizes highly phosphorylated forms of
NF-H (36, 37). The anti-phospho-NF-H antibody clearly detected the
highly phosphorylated NF-H in the lysate of the ASK1 N-expressing
cells, suggesting again that ASK1 N and/or its downstream kinase(s)
phosphorylates neurofilaments.
To examine whether the adenovirus-mediated expression of ASK1 N also
induces phosphorylation of NF-H, we infected WT-PC12 cells with
Ad-ASK1 N or Ad- -galactosidase and lysed them 72 h after
infection. The cell lysate was subjected to Western blot analysis using
anti-NF-H and anti-phospho-NF-H antibodies (Fig. 6B). The
anti-NF-H antibody, but not the anti-phospho-NF-H antibody, detected
basal expression of NF-H as a single band in untreated Ad- -galactosidase-infected cells. When the
Ad- -galactosidase-infected cells were treated with NGF, expression
of NF-H was detected as a slightly broad band, suggesting that 72 h treatment with NGF induces phosphorylation of NF-H to some extent in
WT-PC12 cells. Consistent with the results for PC12-ASK1 N cells,
NF-H expressed in Ad-ASK1 N-infected cells was detected as a doublet
band, the upper band of which was recognized by the anti-phospho-NF-H
antibody, demonstrating that adenovirus-mediated expression of ASK1 N
strongly induced phosphorylation of NF-H in WT-PC12 cells.
To investigate further the kinetics of phosphorylation of NF-H induced
by ASK1, we examined the ASK1 N-induced phosphorylation of NF-H over
a short time course, i.e. within 24 h. In PC12-ASK1 N cells, phosphorylation of NF-H was first detected 12 h after the removal of Tet, following the expression of ASK1 N and the activation of p38, which were readily detected 8 h after Tet removal (Fig. 6C). Since up-regulation of other neuron-specific proteins
required several days of culture after the induction of ASK1 N (data
not shown), phosphorylation of NF-H was a nearly immediate event caused by expression of ASK1 N. These results suggest that p38 activated by
ASK1 or ASK1 itself directly phosphorylates NF-H.
Taken together, these findings indicate that ASK1 N-induced
morphological change of PC12 cells was accompanied by the expression of
neuron-specific proteins and intense phosphorylation of neurofilament proteins. These findings strongly suggest that ASK1 N-induced neurite
outgrowth results from neuronal differentiation of PC12 cells.
ASK1 N-expressing PC12 Cells Survive in Serum-starved
Condition--
NGF induces not only differentiation but also survival
of neurons. To test the possibility that ASK1 also mediates survival signals in PC12 cells, we tested the effect of ASK1 N expression on
serum-starved PC12-ASK1 N cells. PC12-ASK1 N cells were cultured in
different concentrations of Tet in serum-free medium for up to 7 days.
Relative number of surviving cells was determined at different time
points after the reduction of serum and Tet (Fig. 7A). In contrast to the
gradual decrease in the number of ASK1 N-non-expressing cells (Tet
500 ng/ml), the number of ASK1 N-expressing cells (50 or 0 ng/ml of
Tet) was maintained or even increased in the serum-free medium for 7 days, suggesting that ASK1 N-expressing cells were viable in
serum-starved condition. It also appeared that moderate expression of
ASK1 N is required to obtain the optimal survival effect, since this
effect was more prominent in 50 ng/ml than 0 ng/ml Tet. Fig.
7B shows the morphology of the cells expressing (Tet 50 ng/ml) or not expressing (Tet 500 ng/ml) ASK1 N cultured in the
serum-free medium for 5 days. ASK1 N-expressing cells in the
serum-free medium appeared similar to those in the medium containing
1% HS (Fig. 2B), whereas the cells not expressing ASK1 N had an apoptotic appearance and detached from the culture plate. We
also found that PC12-tTA and WT-PC12 cells infected with Ad-ASK1 N, but not with Ad-ASK1KM or Ad- -galactosidase, survived in the serum-free medium (data not shown). These observations suggest that
moderate activation of ASK1 is capable of mediating survival signal in
PC12 cells. ASK1 thus appeared to mediate signals leading to both
differentiation and survival of PC12 cells.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of ASK1 N
expression on serum-starved PC12-ASK1 N
cells. A, time course quantification of surviving
PC12-ASK1 N cells. Using an
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
assay-based Cell Counting Kit-8 (Dojindo), the relative number of
surviving cells in serum-free DMEM containing the indicated
concentration of Tet was determined at different time points after
reduction of serum and Tet, which was performed on day 0. Results are
the means of triplicate determinations ± S.E. from a
representative experiment. B, morphological examination of
the effect of ASK1 N expression on serum-starved PC12-ASK1 N cells.
PC12-ASK1 N cells were cultured in serum-free DMEM containing the
indicated concentration of Tet. Morphology of the cells expressing
(right panel) and not expressing (left panel)
ASK1 N was examined by phase-contrast microscopy 5 days after serum
withdrawal. Bar, 50 µm.
|
|
SB203580 Inhibits ASK1 N-mediated Survival Effect--
We next
assessed the requirement of p38 for the ASK1 N-mediated survival
effect by treatment with SB203580. To avoid evaluating the inhibitory
effect of SB203580 on ASK1 N-induced differentiation, we used
PC12-ASK1 N cells differentiated by expressing ASK1 N under optimal
culture conditions (in DMEM containing 10 ng/ml of Tet and 1% HS) for
1 week. The differentiated PC12-ASK1 N cells were then cultured in
the presence (50 or 200 nM) or absence of SB203580 in
serum-free medium containing 50 ng/ml Tet, the concentration optimal
for ASK1 N-mediated survival effect (Fig. 7A). At
different time points after the deprivation of serum, the relative
number of surviving cells was determined (Fig.
8). In the absence of SB203580, the same
number of differentiated PC12-ASK1 N cells was maintained in the
serum-free medium for 3 days, confirming that ASK1 N-expressing cells
were viable in serum-starved condition. In the presence of SB203580,
however, the number of surviving cells was decreased, indicating that
SB203580 inhibited the survival effect mediated by ASK1 N. These
findings suggest that activation of p38 is required not only for
ASK1 N-induced neurite outgrowth but also for ASK1 N-mediated
survival effect and that p38 is an important downstream mediator of
ASK1 signaling in PC12 cells.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of SB203580 on serum-starved
PC12-ASK1 N cells. PC12-ASK1 N cells
were differentiated in DMEM containing 10 ng/ml Tet and 1% HS for 7 days and then cultured in the presence (50 or 200 nM) or
absence (containing the equivalent volume of dimethyl sulfoxide
(DMSO)) of SB203580 in serum-free medium containing 50 ng/ml
Tet for an additional 3 days. By using a Cell Counting Kit-8, the
relative number of surviving cells was determined at different time
points after the reduction of serum. Results are the means of
triplicate determinations ± S.E. from a representative
experiment.
|
|
 |
DISCUSSION |
In the present study, we demonstrated that expression of ASK1 N
induced neuronal differentiation of undifferentiated PC12 cells, which
was characterized by neurite outgrowth, induction of neuron-specific
proteins, and phosphorylation of neurofilament proteins. In addition,
ASK1 appeared to transduce survival signal in PC12 cells.
Concomitant with the marked neurite outgrowth, rapid and intense
activation of p38 was induced by expression of ASK1 N (Fig. 3). In
contrast, no additional activation of ERK was induced by expression of
ASK1 N, and inhibition of basal activity of ERK did not markedly
decrease the number of ASK1 N-induced neurite-bearing cells (Fig. 4),
suggesting that ASK1 N-induced neurite outgrowth does not require the
activation of ERK. Given that NGF-induced differentiation of PC12 cells
requires activation of the ERK pathway and is sensitive to MEK
inhibitors (7, 10), we suggest that a major set of signaling pathways
mediating the neurite-inducing activity of ASK1 differs from that
activated in NGF-induced differentiation of PC12 cells. Expression of a
dominant-negative mutant form of ASK1 (ASK1KM) consistently did not
inhibit the NGF-induced neurite extension in PC12 cells (data not
shown). Importantly, a p38 inhibitor inhibited ASK1 N-induced neurite
outgrowth (Fig. 5), suggesting that the activation of p38 is required
for this morphological event. Recently, p38 was reported to be required
for NGF- and BMP-2-induced differentiation of PC12 cells (28, 29).
Although it is still unknown whether activation of p38 is sufficient to induce neurite outgrowth and/or neuron-specific markers, p38 appears to
be a generally required element in neuronal differentiation of PC12 cells.
We previously reported that ASK1 activates both the JNK and p38
pathways in various cell types including COS cells, SCGs, and
NGF-differentiated PC12 cells (30, 33). Unexpectedly, ASK1-induced
activation of JNK was relatively weak in undifferentiated PC12 cells.
Whereas intense activation of p38 was easily detected within 24 h
after the induction of ASK1 N, activation of JNK was first detected
only after 48 h (Fig. 3B). Since the neurite outgrowth was induced within 24 h after the induction of ASK1 N, it is
unlikely that the activation of JNK triggers neuronal differentiation
of PC12 cells. JNK and its substrate c-Jun have been suggested to participate in death signaling of neurons, especially trophic factor
deprivation-induced death. Interestingly, it was recently reported that
expression of constitutively active MEKK1 (MEKK1 ) in PC12 cells
induced activation of both JNK and p38 to a similar extent, and that
these cells underwent apoptosis (20), and that a dominant-interfering
c-Jun mutant could inhibit MEKK1 -induced apoptosis, suggesting the
possible involvement of JNK in death signaling in undifferentiated PC12
cells. Our observation that expression of ASK1 N induced
differentiation, but not death, in PC12 cells may be related to the
absence of intense activation of JNK. In addition, expression of
ASK1 N in PC12-ASK1 N cells with the complete absence of Tet (0 ng/ml), but not with the moderate reduction of Tet (50 or 10 ng/ml),
resulted in a decrease in the number of neurite-bearing cells after a
longer period of culture (Fig. 2C). The differential effect
of ASK1 may be explained by the relative increase in JNK activity in
the complete absence of Tet (Fig. 3B). Although the extent
of JNK activation induced by ASK1 N is insufficient to elicit death
of PC12 cells, the weak activation of JNK by ASK1 might antagonize the
neurite-inducing activity of the ASK1-p38 axis. It may also be possible
that optimal balance between activation of the JNK and p38 pathways is
required for ASK1 N-induced neurite outgrowth in PC12 cells.
We found that expression of ASK1 N up-regulated neuron-specific
components of microtubules and strongly induced phosphorylation of
neurofilament proteins (Fig. 6), suggesting that neurite outgrowth induced by expression of ASK1 N indeed resulted from neuronal differentiation of PC12 cells. Surprisingly, the extent of
phosphorylation of NF-H induced by expression of ASK1 N was much more
prominent than that induced by treatment with NGF. Phosphorylation of
NF-H is thus a major characteristic of ASK1 N-induced differentiation of PC12 cells. NF-M and NF-H are among the most highly phosphorylated proteins in the nervous system. Although the role of their
phosphorylation is not fully understood, phosphorylated NF-M and NF-H
are major components of the cytoskeleton in many types of mature
neurons and are particularly abundant in myelinated axons (41). Most of
the phosphorylation sites in NF-M and NF-H are located in the C-terminal tail region containing multiple copies of Lys-Ser-Pro (KSP)
motif (42, 43). To date, several kinases including
cyclin-dependent kinase 5 (Cdk5) (44), glycogen synthase
kinase-3 (GSK-3) (45), ERK1 and -2 (46, 47), and JNK1 (48, 49) have
been implicated in the phosphorylation of NF-M and NF-H. Relevant to
the present study, it is of interest that proline-directed MAP kinases
ERK and JNK are reported to phosphorylate directly NF-H (47, 48), since
p38, another proline-directed kinase, may phosphorylate NF-H in
ASK1 N-expressing PC12 cells. Together with the observation that the
phosphorylation of NF-H was detectable soon after the activation of p38
(Fig. 6C), it is possible that p38, rather than JNK,
activated by ASK1 directly phosphorylates NF-H. Alternatively, other
unidentified kinase(s) activated by ASK1 or ASK1 itself may
phosphorylate NF-H.
The observation that ASK1 N-expressing cells could survive in
serum-starved condition suggests another unexpected function of ASK1
(Fig. 7). We found that expression of ASK1 N induced apoptosis in
NGF-differentiated PC12 cells and SCGs (33). Although these findings
appear to contradict those of the present study, we suggest that the
expression level of ASK1 N could determine the cell fate; moderate
expression of ASK1 N induces differentiation and survival, whereas
excessive ASK1 activity induces apoptosis in PC12 cells. In fact, we
observed that excess overexpression of ASK1 N induced apoptosis even
in undifferentiated PC12 cells (data not shown). On the other hand, it
is difficult to compare the precise expression level of transfected
ASK1 N in undifferentiated PC12 cells with that in NGF-differentiated
PC12 cells or SCGs; we also consider the possibility that ASK1 may
preferentially mediate apoptosis signal in NGF-differentiated PC12
cells and SCGs due to the different cellular context. We are currently
investigating the difference in the ASK1-induced activation of
downstream signaling pathways between undifferentiated and
NGF-differentiated PC12 cells.
Similar to the ASK1 N-induced neurite outgrowth, ASK1 N-mediated
survival effect was inhibited by a p38 inhibitor (Fig. 8), suggesting
that the activation of p38 plays crucial roles in both differentiation
and survival induced by ASK1. However, in the absence of data in
primary neurons, we cannot exclude a possibility that the
differentiation/pro-survival effects of ASK1 might be a PC12-specific
phenomenon. Future experiments using undifferentiated neuronal
precursor cells may enable understanding of diverse roles of ASK1 in
neuronal physiology.
 |
ACKNOWLEDGEMENTS |
We thank K. Miyazono, Y. Sahara, K. Tobiume,
Y. Sawada, A. Matsuzawa, Y. Mochida, S. Inoshita, K. Morita, and T. Kanamoto for valuable discussions.
 |
FOOTNOTES |
*
This work was supported by CREST of Japan Science and
Technology.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biomaterials
Science, Faculty of Dentistry, Tokyo Medical and Dental University,
1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8549, Japan. Tel.:
+81-3-5803-5471; Fax: +81-3-5803-0192; E-mail:
takeda.det2@dent.tmd.ac.jp (K. T.), ichijo.det2@dent.tmd.ac.jp
(H. I.).
 |
ABBREVIATIONS |
The abbreviations used are:
NGF, nerve growth
factor;
ASK1, apoptosis signal-regulating kinase 1;
ERK, extracellular
signal-regulating kinase;
HS, horse serum;
JNK, c-Jun N-terminal
kinase;
MAPK, mitogen-activated kinase;
SCG, superior cervical ganglia;
Tet, tetracycline;
MAP, mitogen-activated protein;
MEK, MAPK/ERK
kinase;
SAPK, stress-activated protein kinase;
BMP, bone morphogenetic
protein;
TNF, tumor necrosis factor;
DMEM, Dulbecco's modified
Eagle's medium;
FCS, fetal calf serum;
HA, hemagglutinin;
PBS, phosphate-buffered saline;
WT, wild type;
m.o.i., multiplicity of
infection;
tubulin- III, -tubulin isoform III;
Ad, adenovirus;
NF-L, neurofilament light;
NF-M, neurofilament medium;
NF-H, neurofilament heavy;
hyg, hygromycin.
 |
REFERENCES |
| 1.
|
Greene, L. A.,
and Tischler, A. S.
(1976)
Proc. Natl. Acad. Sci. U. S. A.
73,
2424-2428[Abstract/Free Full Text]
|
| 2.
|
Chao, M. V.
(1992)
Cell
68,
995-997[Medline]
[Order article via Infotrieve]
|
| 3.
|
Wood, K. W.,
Sarnecki, C.,
Roberts, T. M.,
and Blenis, J.
(1992)
Cell
68,
1041-1050[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Nishida, E.,
and Gotoh, Y.
(1993)
Trends Biochem. Sci.
18,
128-131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Cowley, S.,
Paterson, H.,
Kemp, P.,
and Marshall, C. J.
(1994)
Cell
77,
841-852[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Fukuda, M.,
Gotoh, Y.,
Tachibana, T.,
Dell, K.,
Hattori, S.,
Yoneda, Y.,
and Nishida, E.
(1995)
Oncogene
11,
239-244[Medline]
[Order article via Infotrieve]
|
| 7.
|
Pang, L.,
Sawada, T.,
Decker, S. J.,
and Saltiel, A. R.
(1995)
J. Biol. Chem.
270,
13585-13588[Abstract/Free Full Text]
|
| 8.
|
Qui, M. S.,
and Green, S. H.
(1992)
Neuron
9,
705-717[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Traverse, S.,
Gomez, N.,
Paterson, H.,
Marshall, C.,
and Cohen, P.
(1992)
Biochem. J.
288,
351-355
|
| 10.
|
Marshall, C. J.
(1995)
Cell
80,
179-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
York, R. D.,
Yao, H.,
Dillon, T.,
Ellig, C. L.,
Eckert, S. P.,
McCleskey, E. W.,
and Stork, P. J. S.
(1998)
Nature
392,
622-626[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Sano, M.,
and Kitajima, S.
(1998)
Brain Res.
785,
299-308[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Iwasaki, S.,
Hattori, A.,
Sato, M.,
Tsujimoto, M.,
and Kohno, M.
(1996)
J. Biol. Chem.
271,
17360-17365[Abstract/Free Full Text]
|
| 14.
|
Raingeaud, J.,
Gupta, S.,
Rogers, J. S.,
Dickens, M.,
Han, J.,
Ulevitch, R. J.,
and Davis, R. J.
(1995)
J. Biol. Chem.
270,
7420-7426[Abstract/Free Full Text]
|
| 15.
|
Verheij, M.,
Bose, R.,
Lin, X. H.,
Yao, B.,
Jarvis, W. D.,
Grant, S.,
Birrer, M. J.,
Szabo, E.,
Zon, L. I.,
Kyriakis, J. M.,
Haimovitz-Friedman, A.,
Fuks, Z.,
and Kolesnick, R. N.
(1996)
Nature
380,
75-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Kyriakis, J. M.,
and Avruch, J.
(1996)
BioEssays
18,
567-577[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Xia, Z.,
Dickens, M.,
Raingeaud, J.,
Davis, R. J.,
and Greenberg, M. E.
(1995)
Science
270,
1326-1331[Abstract/Free Full Text]
|
| 18.
|
Kummer, J. L.,
Rao, P. K.,
and Heidenreich, K. A.
(1997)
J. Biol. Chem.
272,
20490-20494[Abstract/Free Full Text]
|
| 19.
|
Watson, A.,
Eilers, A.,
Lallemand, D.,
Kyriakis, J.,
Rubin, L. L.,
and Ham, J.
(1998)
J. Neurosci.
18,
751-762[Abstract/Free Full Text]
|
| 20.
|
Le-Niculescu, H.,
Bonfoco, E.,
Kasuya, Y.,
Claret, F.-X.,
Green, D. R.,
and Karin, M.
(1999)
Mol. Cell. Biol.
19,
751-763[Abstract/Free Full Text]
|
| 21.
|
Yang, D. D.,
Kuan, C.-Y.,
Whitmarsh, A. J.,
Rincón, M.,
Zheng, T. S.,
Davis, R. J.,
Rakic, P.,
and Flavell, R. A.
(1997)
Nature
389,
865-870[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Behrens, A.,
Sibilia, M.,
and Wagner, E. F.
(1999)
Nat. Genet.
21,
326-329[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Kuan, C.-Y.,
Yang, D. D.,
Roy, D. R. S.,
Davis, R. J.,
Rakic, P.,
and Flavell, R. A.
(1999)
Neuron
22,
667-676[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Heasley, L. E.,
Storey, B.,
Fanger, G. R.,
Butterfield, L.,
Zamarripa, J.,
Blumberg, D.,
and Maue, R. A.
(1996)
Mol. Cell. Biol.
16,
648-656[Abstract]
|
| 25.
|
Leppä, S.,
Saffrich, R.,
Ansorge, W.,
and Bohmann, D.
(1998)
EMBO J.
17,
4404-4413[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Yao, R.,
Yoshihara, M.,
and Osada, H.
(1997)
J. Biol. Chem.
272,
18261-18266[Abstract/Free Full Text]
|
| 27.
|
Xing, J.,
Kornhauser, J. M.,
Xia, Z.,
Thiele, E. A.,
and Greenberg, M. E.
(1998)
Mol. Cell. Biol.
18,
1946-1955[Abstract/Free Full Text]
|
| 28.
|
Morooka, T.,
and Nishida, E.
(1998)
J. Biol. Chem.
273,
24285-24288[Abstract/Free Full Text]
|
| 29.
|
Iwasaki, S.,
Iguchi, M.,
Watanabe, K.,
Hoshino, R.,
Tsujimoto, M.,
and Kohno, M.
(1999)
J. Biol. Chem.
274,
26503-26510[Abstract/Free Full Text]
|
| 30.
|
Ichijo, H.,
Nishida, E.,
Irie, K.,
ten Dijke, P.,
Saitoh, M.,
Moriguchi, T.,
Takagi, M.,
Matsumoto, K.,
Miyazono, K.,
and Gotoh, Y.
(1997)
Science
275,
90-94[Abstract/Free Full Text]
|
| 31.
|
Saitoh, M.,
Nishitoh, H.,
Fujii, M.,
Takeda, K.,
Tobiume, K.,
Sawada, Y.,
Kawabata, M.,
Miyazono, K.,
and Ichijo, H.
(1998)
EMBO J.
17,
2596-2606[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Wang, T.-H.,
Popp, D. M.,
Wang, H.-S.,
Saitoh, M.,
Mural, J. G.,
Henley, D. C.,
Ichijo, H.,
and Wimalasena, J.
(1999)
J. Biol. Chem.
274,
8208-8216[Abstract/Free Full Text]
|
| 33.
|
Kanamoto, T.,
Mota, M.,
Takeda, K.,
Rubin, L.,
Miyazono, K.,
Ichijo, H.,
and Bazenet, C. E.
(2000)
Mol. Cell. Biol.
20,
196-204[Abstract/Free Full Text]
|
| 34.
|
Nishitoh, H.,
Saitoh, M.,
Mochida, Y.,
Takeda, K.,
Nakano, H.,
Rothe, M.,
Miyazono, K.,
and Ichijo, H.
(1998)
Mol. Cell
2,
389-395[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Chang, H. Y.,
Nishitoh, H.,
Yang, X.,
Ichijo, H.,
and Baltimore, D.
(1998)
Science
281,
1860-1863[Abstract/Free Full Text]
|
| 36.
|
Lee, V. M.-Y.,
Carden, M. J.,
Schlaepfer, W. W.,
and Trojanowski, J. Q.
(1987)
J. Neurosci.
7,
3474-3488[Abstract]
|
| 37.
|
Carden, M. J.,
Trojanowski, J. Q.,
Schlaepfer, W. W.,
and Lee, V. M.-Y.
(1987)
J. Neurosci.
7,
3489-3504[Abstract]
|
| 38.
|
Lee, M. K.,
Tuttle, J. B.,
Rebhun, L. I.,
Cleveland, D. W.,
and Frankfurter, A.
(1990)
Cell Motil. Cytoskeleton
17,
118-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Binder, L. I.,
Frankfurter, A.,
and Rebhun, L. I.
(1985)
J. Cell Biol.
101,
1371-1378[Abstract/Free Full Text]
|
| 40.
|
Sadot, E.,
Barg, J.,
Rasouly, D.,
Lazarovici, P.,
and Ginzburg, I.
(1995)
J. Cell Sci.
108,
2857-2864[Abstract]
|
| 41.
|
Julien, J.-P.,
and Mushynski, W. E.
(1998)
Prog. Nucleic Acids Res. Mol. Biol.
61,
1-23[Medline]
[Order article via Infotrieve]
|
| 42.
|
Lee, V. M.,
Otvos, L., Jr.,
Carden, M. J.,
Hollosi, M.,
Dietzschold, B.,
and Lazzarini, R. A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
1998-2002[Abstract/Free Full Text]
|
| 43.
|
Elhanany, E.,
Jaffe, H.,
Link, W. T.,
Sheeley, D. M.,
Gainer, H.,
and Pant, H. C.
(1994)
J. Neurochem.
63,
2324-2335[Medline]
[Order article via Infotrieve]
|
| 44.
|
Sun, D.,
Leung, C. L.,
and Liem, R. K. H.
(1996)
J. Biol. Chem.
271,
14245-14251[Abstract/Free Full Text]
|
| 45.
|
Guan, R. J.,
Khatra, B. S.,
and Cohlberg, J. A.
(1991)
J. Biol. Chem.
266,
8262-8267[Abstract/Free Full Text]
|
| 46.
|
Roder, H. M.,
Hoffman, F. J.,
and Schroder, W.
(1995)
J. Neurochem.
64,
2203-2212[Medline]
[Order article via Infotrieve]
|
| 47.
|
Veeranna,
Amin, N. D.,
Ahn, N. G.,
Jaffe, H.,
Winters, C. A.,
Grant, P.,
and Pant, H. C.
(1998)
J. Neurosci.
18,
4008-4021[Abstract/Free Full Text]
|
| 48.
|
Giasson, B. I.,
and Mushynski, W. E.
(1996)
J. Biol. Chem.
271,
30404-30409[Abstract/Free Full Text]
|
| 49.
|
Giasson, B. I.,
and Mushynski, W. E.
(1997)
J. Neurosci.
17,
9466-9472[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Yan and B. F. Hales
p38 and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Signaling Pathways Play Distinct Roles in the Response of Organogenesis-Stage Embryos to a Teratogen
J. Pharmacol. Exp. Ther.,
September 1, 2008;
326(3):
764 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Min, Y. Lin, S. Tang, L. Yu, H. Zhang, T. Wan, T. Luhn, H. Fu, and H. Chen
AIP1 Recruits Phosphatase PP2A to ASK1 in Tumor Necrosis Factor-Induced ASK1-JNK Activation
Circ. Res.,
April 11, 2008;
102(7):
840 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Roesslein, M. Frick, V. Auwaerter, M. Humar, U. Goebel, C. Schwer, K. K. Geiger, H. L. Pahl, B. H. J. Pannen, and T. Loop
Sevoflurane-Mediated Activation of p38-Mitogen-Activated Stresskinase is Independent of Apoptosis in Jurkat T-Cells
Anesth. Analg.,
April 1, 2008;
106(4):
1150 - 1160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fujino, T. Noguchi, A. Matsuzawa, S. Yamauchi, M. Saitoh, K. Takeda, and H. Ichijo
Thioredoxin and TRAF Family Proteins Regulate Reactive Oxygen Species-Dependent Activation of ASK1 through Reciprocal Modulation of the N-Terminal Homophilic Interaction of ASK1
Mol. Cell. Biol.,
December 1, 2007;
27(23):
8152 - 8163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Kutuzov, A. V. Andreeva, and T. A. Voyno-Yasenetskaya
Regulation of apoptosis signal-regulating kinase 1 degradation by G{alpha}13
FASEB J,
November 1, 2007;
21(13):
3727 - 3736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Nadeau, S. J. Charette, M. B. Toledano, and J. Landry
Disulfide Bond-mediated Multimerization of Ask1 and Its Reduction by Thioredoxin-1 Regulate H2O2-induced c-Jun NH2-terminal Kinase Activation and Apoptosis
Mol. Biol. Cell,
October 1, 2007;
18(10):
3903 - 3913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Farley, G. Pedraza-Alva, D. Serrano-Gomez, V. Nagaleekar, A. Aronshtam, T. Krahl, T. Thornton, and M. Rincon
p38 Mitogen-Activated Protein Kinase Mediates the Fas-Induced Mitochondrial Death Pathway in CD8+ T Cells.
Mol. Cell. Biol.,
March 1, 2006;
26(6):
2118 - 2129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Xiang, T. Seki, M. D. Schuster, P. Witkowski, A. J. Boyle, F. See, T. P. Martens, A. Kocher, H. Sondermeijer, H. Krum, et al.
Catalytic Degradation of Vitamin D Up-regulated Protein 1 mRNA Enhances Cardiomyocyte Survival and Prevents Left Ventricular Remodeling after Myocardial Ischemia
J. Biol. Chem.,
November 25, 2005;
280(47):
39394 - 39402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Izumi, S. Kim-Mitsuyama, M. Yoshiyama, T. Omura, M. Shiota, A. Matsuzawa, T. Yukimura, T. Murohara, M. Takeya, H. Ichijo, et al.
Important Role of Apoptosis Signal-Regulating Kinase 1 in Ischemia-Induced Angiogenesis
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2005;
25(9):
1877 - 1883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, R. Zhang, D. Luo, S.-J. Park, Q. Wang, Y. Kim, and W. Min
Tumor Necrosis Factor {alpha}-induced Desumoylation and Cytoplasmic Translocation of Homeodomain-interacting Protein Kinase 1 Are Critical for Apoptosis Signal-regulating Kinase 1-JNK/p38 Activation
J. Biol. Chem.,
April 15, 2005;
280(15):
15061 - 15070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Su, M.-T. Lin, C.-C. Hong, C.-C. Chang, S.-G. Shiah, C.-W. Wu, S.-T. Chen, Y.-P. Chau, and M.-L. Kuo
Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells
Carcinogenesis,
January 1, 2005;
26(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Matsukawa, A. Matsuzawa, K. Takeda, and H. Ichijo
The ASK1-MAP Kinase Cascades in Mammalian Stress Response
J. Biochem.,
September 1, 2004;
136(3):
261 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kishida, H. Yamamoto, and A. Kikuchi
Wnt-3a and Dvl Induce Neurite Retraction by Activating Rho-Associated Kinase
Mol. Cell. Biol.,
May 15, 2004;
24(10):
4487 - 4501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Saadatzadeh, K. Bijangi-Vishehsaraei, P. Hong, H. Bergmann, and L. S. Haneline
Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic Pathway
J. Biol. Chem.,
April 16, 2004;
279(16):
16805 - 16812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Park, J.-W. Yu, J.-H. Cho, M.-S. Kim, S.-H. Huh, K. Ryoo, and E.-J. Choi
Inhibition of Apoptosis Signal-regulating Kinase 1 by Nitric Oxide through a Thiol Redox Mechanism
J. Biol. Chem.,
February 27, 2004;
279(9):
7584 - 7590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Faigle, A. Brederlau, M. Elmi, Y. Arvidsson, T. S. Hamazaki, H. Uramoto, and K. Funa
ASK1 Inhibits Astroglial Development via p38 Mitogen-Activated Protein Kinase and Promotes Neuronal Differentiation in Adult Hippocampus-Derived Progenitor Cells
Mol. Cell. Biol.,
January 1, 2004;
24(1):
280 - 293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Izumi, S. Kim, M. Yoshiyama, Y. Izumiya, K. Yoshida, A. Matsuzawa, H. Koyama, Y. Nishizawa, H. Ichijo, J. Yoshikawa, et al.
Activation of Apoptosis Signal-Regulating Kinase 1 in Injured Artery and Its Critical Role in Neointimal Hyperplasia
Circulation,
December 2, 2003;
108(22):
2812 - 2818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Izumiya, S. Kim, Y. Izumi, K. Yoshida, M. Yoshiyama, A. Matsuzawa, H. Ichijo, and H. Iwao
Apoptosis Signal-Regulating Kinase 1 Plays a Pivotal Role in Angiotensin II-Induced Cardiac Hypertrophy and Remodeling
Circ. Res.,
October 31, 2003;
93(9):
874 - 883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamagishi, M. Yamada, H. Koshimizu, S. Takai, H. Hatanaka, K. Takeda, H. Ichijo, K. Shimoke, and T. Ikeuchi
Apoptosis-Signal Regulating Kinase-1 Is Involved in the Low Potassium-Induced Activation of p38 Mitogen-Activated Protein Kinase and c-Jun in Cultured Cerebellar Granule Neurons
J. Biochem.,
June 1, 2003;
133(6):
719 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Jibiki, S. Hashimoto, S. Maruoka, Y. Gon, A. Matsuzawa, H. Nishitoh, H. Ichijo, and T. Horie
Apoptosis Signal-Regulating Kinase 1-Mediated Signaling Pathway Regulates Nitric Oxide-Induced Activator Protein-1 Activation in Human Bronchial Epithelial Cells
Am. J. Respir. Crit. Care Med.,
March 15, 2003;
167(6):
856 - 861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Park, S.-G. Cho, C. K. Kim, H. S. Hwang, K. T. Noh, M.-S. Kim, S.-H. Huh, M. J. Kim, K. Ryoo, E. K. Kim, et al.
Heat Shock Protein Hsp72 Is a Negative Regulator of Apoptosis Signal-Regulating Kinase 1
Mol. Cell. Biol.,
November 15, 2002;
22(22):
7721 - 7730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matsuura, H. Nishitoh, K. Takeda, A. Matsuzawa, T. Amagasa, M. Ito, K. Yoshioka, and H. Ichijo
Phosphorylation-dependent Scaffolding Role of JSAP1/JIP3 in the ASK1-JNK Signaling Pathway. A NEW MODE OF REGULATION OF THE MAP KINASE CASCADE
J. Biol. Chem.,
October 18, 2002;
277(43):
40703 - 40709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu and W. Min
Thioredoxin Promotes ASK1 Ubiquitination and Degradation to Inhibit ASK1-Mediated Apoptosis in a Redox Activity-Independent Manner
Circ. Res.,
June 28, 2002;
90(12):
1259 - 1266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Doggett, J. T. Swarthout, S. C. Jefcoat Jr., D. Wilhelm, A. Dieckmann, P. Angel, and N. C. Partridge
Parathyroid Hormone Inhibits c-Jun N-Terminal Kinase Activity in Rat Osteoblastic Cells by a Protein Kinase A-Dependent Pathway
Endocrinology,
May 1, 2002;
143(5):
1880 - 1888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hirotani, K. Otsu, K. Nishida, Y. Higuchi, T. Morita, H. Nakayama, O. Yamaguchi, T. Mano, Y. Matsumura, H. Ueno, et al.
Involvement of Nuclear Factor-{kappa}B and Apoptosis Signal-Regulating Kinase 1 in G-Protein-Coupled Receptor Agonist-Induced Cardiomyocyte Hypertrophy
Circulation,
January 29, 2002;
105(4):
509 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Allen, D. A. Linseman, H. Udo, M. Xu, J. B. Schaack, B. Varnum, E. R. Kandel, K. A. Heidenreich, and M. E. Wierman
Novel Mechanism for Gonadotropin-Releasing Hormone Neuronal Migration Involving Gas6/Ark Signaling to p38 Mitogen-Activated Protein Kinase
Mol. Cell. Biol.,
January 15, 2002;
22(2):
599 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Kim, G. Khursigara, X. Sun, T. F. Franke, and M. V. Chao
Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1
Mol. Cell. Biol.,
February 1, 2001;
21(3):
893 - 901.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. T. Coffey, V. Hongisto, M. Dickens, R. J. Davis, and M. J. Courtney
Dual Roles for c-Jun N-Terminal Kinase in Developmental and Stress Responses in Cerebellar Granule Neurons
J. Neurosci.,
October 15, 2000;
20(20):
7602 - 7613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mochida, K. Takeda, M. Saitoh, H. Nishitoh, T. Amagasa, J. Ninomiya-Tsuji, K. Matsumoto, and H. Ichijo
ASK1 Inhibits Interleukin-1-induced NF-kappa B Activity through Disruption of TRAF6-TAK1 Interaction
J. Biol. Chem.,
October 13, 2000;
275(42):
32747 - 32752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hatai, A. Matsuzawa, S. Inoshita, Y. Mochida, T. Kuroda, K. Sakamaki, K. Kuida, S. Yonehara, H. Ichijo, and K. Takeda
Execution of Apoptosis Signal-regulating Kinase 1 (ASK1)-induced Apoptosis by the Mitochondria-dependent Caspase Activation
J. Biol. Chem.,
August 18, 2000;
275(34):
26576 - 26581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sayama, Y. Hanakawa, Y. Shirakata, K. Yamasaki, Y. Sawada, L. Sun, K. Yamanishi, H. Ichijo, and K. Hashimoto
Apoptosis Signal-regulating Kinase 1 (ASK1) Is an Intracellular Inducer of Keratinocyte Differentiation
J. Biol. Chem.,
January 5, 2001;
276(2):
999 - 1004.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|